[1]
“Comparison of the safety and efficacy of ivabradine and nebivolol mono- and combination therapies in the treatment of stable angina pectoris patients with left ventricular dysfunction”, Bangladesh J Pharmacol, vol. 8, no. 3, pp. 283–291, Jun. 2013, doi: 10.3329/bjp.v8i3.15118.